Ameraudi Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Sell |
3,747
-471
| -11% | -$39.1K | 0.16% | 46 |
|
|
2025
Q1 | $342K | Sell |
4,218
-172
| -4% | -$13.9K | 0.2% | 43 |
|
|
2024
Q4 | $395K | Sell |
4,390
-89
| -2% | -$8.02K | 0.22% | 42 |
|
|
2024
Q3 | $443K | Sell |
4,479
-2,108
| -32% | -$208K | 0.2% | 40 |
|
|
2024
Q2 | $611K | Sell |
6,587
-280
| -4% | -$26K | 0.28% | 33 |
|
|
2024
Q1 | $652K | Sell |
6,867
-31,094
| -82% | -$2.95M | 0.3% | 31 |
|
|
2023
Q4 | $3.39M | Sell |
37,961
-25,609
| -40% | -$2.29M | 1.49% | 20 |
|
|
2023
Q3 | $4.64M | Sell |
63,570
-10,301
| -14% | -$752K | 2.21% | 13 |
|
|
2023
Q2 | $6.15M | Sell |
73,871
-1,405
| -2% | -$117K | 2.69% | 12 |
|
|
2023
Q1 | $5.74M | Buy |
75,276
+577
| +0.8% | +$44K | 2.5% | 13 |
|
|
2022
Q4 | $6.2M | Buy |
74,699
+1,744
| +2% | +$145K | 2.67% | 13 |
|
|
2022
Q3 | $5.79M | Sell |
72,955
-500
| -0.7% | -$39.7K | 2.6% | 15 |
|
|
2022
Q2 | $5.46M | Buy |
+73,455
| New | +$5.46M | 2.25% | 17 |
|